U.S. FDA approved first gene therapy for treatment of patients with Duchenne Muscular Dystrophy
On Jun. 22, 2023, the U.S. Food and Drug Administration (FDA) approved Sarepta Therapeutics’s Elevidys, the first gene…
On Jun. 22, 2023, the U.S. Food and Drug Administration (FDA) approved Sarepta Therapeutics’s Elevidys, the first gene…
On May 31, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $10 million to five facilities as…
On Mar. 17, 2023, PrairiesCan announced $80,514,000 over five years to support the Canadian Critical Drug Initiative and…
On Mar. 8, 2023, Amphastar Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) had granted approval…
On Jan. 25, 2023, it was reported that adults living in rural areas of the United States have…
On Nov. 18, 2022, Pfizer and BioNTech announced results from an analysis examining the immune response induced by…
On Oct. 3, 2022, the Nobel Prize in Physiology or Medicine was awarded to was awarded to Svante…
On Aug. 31, 2022, a new front-door to the University of Victoria opened to advance health and life…
On Jul. 28, 2022, AlphaFold, in partnership with EMBL’s European Bioinformatics Institute (EMBL-EBI), announced they we’re releasing predicted…
COVID-19 Vacations Redux iIlustrates once again the pits and perils vacation travelers face as they begin their Summer…
Play the COVID-19 Wheel of Fortune and see how lucky you are! You have two wheels to choose…
On Jun. 2, 2022, the National Institutes of Health (NIH) reported that the Age-Related Eye Disease Studies (AREDS…
On Apr. 1, 2022, Merck and Ridgeback Biotherapeutics announced that data evaluating LAGEVRIO(molnupiravir), an investigational oral antiviral COVID-19…
On Mar. 21, 2022, in support of the Cancer Moonshot goal of fostering data sharing in cancer research,…
On Feb. 2, 2022, President Biden announced a reignition of the Cancer Moonshot, that highlighted new goals: to…
On Jan. 28, 2022, Merck and Ridgeback Biotherapeutics announced data from six preclinical studies demonstrating that molnupiravir, an…
On Jan. 18, 2022, Merck and Ridgeback Biotherapeutics announced the signing of a long-term supply agreement with the…
On Dec. 23, 2021, Merck and Ridgeback Biotherapeutics announced that the U.S. Food and Drug Administration (FDA) had…
On Dec. 22, 2021, Gilead Sciences announced full results from a Phase 3 investigational study evaluating the efficacy…
The COVID-19 Roller Coaster is a wild ride, strap yourself in and hold on… Cast of Characters: Senator…
On Oct. 29, 2021, Oregon Health & Science University’s (OHSU) board of directors approved a project to expand…
On Oct. 26, 2021, BioNTech announce that the Company planned to initiate the construction of the first state-of-the-art…
On Oct. 12, 2021, National Resilience announced a strategic collaboration with Children’s Hospital of Philadelphia (CHOP) to implement…
A tomb illustration in Memphis, Egypt, depictded a patient being bled from the foot and neck. Though the…
Around 600 BCE, Chinese healers created the first antibiotic – moldy soybean curds – to treat boils.
On Aug. 27, 2021, researchers at University of British Columbia’s (UBC) faculty of medicine and BC Cancer Research…
On Jul. 26, 2021, the American Medical Association (AMA) call for all health care and long-term care employers…
Planning a Summer vacation? Where to go? How about going to one of those large events with tens…
On Jul. 16, 2021, Merck announced the U.S. Food and Drug Administration (FDA) had approved VAXNEUVANCE (Pneumococcal 15-valent…
Cast of Characters: Jay Inslee, Governor, Washington | Gavin Newsom, Governor, California | Doug Ducey, Governor, Arizona |…